176 related articles for article (PubMed ID: 18257752)
1. Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy.
Atkinson TJ
Obes Rev; 2008 Mar; 9(2):108-20. PubMed ID: 18257752
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine control of food intake.
Valassi E; Scacchi M; Cavagnini F
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
[TBL] [Abstract][Full Text] [Related]
3. Endocrine receptors as targets for new drugs.
Altman J
Neuroendocrinology; 2006; 83(5-6):282-8. PubMed ID: 16926529
[TBL] [Abstract][Full Text] [Related]
4. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
5. Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors.
Jensen MD
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():143S-149S. PubMed ID: 16931496
[TBL] [Abstract][Full Text] [Related]
6. A critical review of the cannabinoid receptor as a drug target for obesity management.
Akbas F; Gasteyger C; Sjödin A; Astrup A; Larsen TM
Obes Rev; 2009 Jan; 10(1):58-67. PubMed ID: 18721231
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of (ant)-agonists that alter appetite and adiposity.
Van der Ploeg LH; Kanatani A; MacNeil D; Ming Fong T; Strack A; Nargund R; Guan XM
Prog Brain Res; 2006; 153():107-18. PubMed ID: 16876570
[TBL] [Abstract][Full Text] [Related]
8. Novel therapeutic targets for appetite regulation.
Small CJ; Parkinson JR; Bloom SR
Curr Opin Investig Drugs; 2005 Apr; 6(4):369-72. PubMed ID: 15898343
[TBL] [Abstract][Full Text] [Related]
9. [Peptides are opening the door for novel treatments of obesity and loss of appetite].
Broberger C; Hökfelt T
Lakartidningen; 2002 Dec; 99(49):4982-9. PubMed ID: 12522988
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic management of obesity.
Kushner RF
Pediatr Blood Cancer; 2012 Jan; 58(1):140-3. PubMed ID: 22009632
[TBL] [Abstract][Full Text] [Related]
11. Molecular network of obesity: what does it promise for pharmacotherapy?
Myslobodsky M
Obes Rev; 2008 May; 9(3):236-45. PubMed ID: 18034789
[TBL] [Abstract][Full Text] [Related]
12. Neuropharmacology of human appetite expression.
Halford JC; Harrold JA
Dev Disabil Res Rev; 2008; 14(2):158-64. PubMed ID: 18646016
[TBL] [Abstract][Full Text] [Related]
13. The obesity pipeline: current strategies in the development of anti-obesity drugs.
Cooke D; Bloom S
Nat Rev Drug Discov; 2006 Nov; 5(11):919-31. PubMed ID: 17080028
[TBL] [Abstract][Full Text] [Related]
14. Histamine and the regulation of body weight.
Jørgensen EA; Knigge U; Warberg J; Kjaer A
Neuroendocrinology; 2007; 86(3):210-4. PubMed ID: 17848791
[TBL] [Abstract][Full Text] [Related]
15. Obesity in neurobiology.
Knecht S; Ellger T; Levine JA
Prog Neurobiol; 2008 Jan; 84(1):85-103. PubMed ID: 18006138
[TBL] [Abstract][Full Text] [Related]
16. Prospects for an anti-ghrelin vaccine to treat obesity.
Carlson MJ; Cummings DE
Mol Interv; 2006 Oct; 6(5):249-52. PubMed ID: 17035664
[TBL] [Abstract][Full Text] [Related]
17. Regulation of appetite to treat obesity.
Kim GW; Lin JE; Valentino MA; Colon-Gonzalez F; Waldman SA
Expert Rev Clin Pharmacol; 2011 Mar; 4(2):243-59. PubMed ID: 21666781
[TBL] [Abstract][Full Text] [Related]
18. Regulation of food intake by gastrointestinal hormones.
Baynes KC; Dhillo WS; Bloom SR
Curr Opin Gastroenterol; 2006 Nov; 22(6):626-31. PubMed ID: 17053440
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine and physiological regulation of intake with particular reference to domesticated ruminant animals.
Roche JR; Blache D; Kay JK; Miller DR; Sheahan AJ; Miller DW
Nutr Res Rev; 2008 Dec; 21(2):207-34. PubMed ID: 19087372
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced hyperphagia: what can we learn from psychiatric medications?
Jensen GL
JPEN J Parenter Enteral Nutr; 2008; 32(5):578-81. PubMed ID: 18753398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
